XML 54 R40.htm IDEA: XBRL DOCUMENT v3.21.4
Stock Incentive Plans (Tables) - Planet Labs Inc [Member]
9 Months Ended 12 Months Ended
Oct. 31, 2021
Jan. 31, 2021
Stock Incentive Plans [Line Items]    
Summary of share based payment arrangement option activity
A summary of stock option activity under the Plan is as follows:
 
    
Options Outstanding
 
    
Number of
Options
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Remaining
Term (Years)
    
Aggregate
Intrinsic
Value
(in thousands)
 
Balances at January 31, 2021
     25,620,937      $ 4.88      7.21   
Exercised
     (2,749,340      9.02      
Granted
     7,957,396        13.92      
Forfeited
     (1,767,093      5.88      
  
 
 
          
Balances at October 31, 2021
     29,061,900    $ 6.90      7.17    $ 264,080
  
 
 
          
Vested and exercisable
     17,187,395      $ 4.56      5.89    $ 196,513
A summary of stock option activity under the Plan is as follows:
 
    
Options Outstanding
 
    
Number of

Options
    
Weighted

Average

Exercise

Price
    
Weighted

Average

Remaining

Term (Years)
    
Aggregate

Intrinsic

Value

(in thousands)
 
Balances at February 1, 2019
     15,684,075    $ 3.42      7.07     
Exercised
     (111,910      2.36      
Granted
     6,876,680      6.01      
Forfeited
     (2,355,113      4.71      
  
 
 
          
Balances at January 31, 2020
     20,093,732      4.16      7.13   
Exercised
     (1,090,700      0.49      
Granted
     8,000,619      6.19      
Forfeited
     (1,382,714      5.45      
  
 
 
          
Balances at January 31, 2021
     25,620,937    $ 4.88      7.21    $ 80,964
Vested and exercisable
     15,849,747    $ 4.14      6.15    $ 61,882
Summary of Share based payment arrangement option exercise price range  
A summary of options outstanding and exercisable by price at January 31, 2021 are as follows:
 
    
Options Outstanding
    
Options Exercisable
 
Exercise Price
  
Number of

Options
    
Weighted

Average

Remaining

Contractual

Life (in Years)
    
Number of

Options
    
Weighted

Average

Remaining

Contractual

Life (in Years)
 
$0.00002
     48,995      0.64        48,995      0.64  
0.014
     187,500      0.79        187,500      0.79  
0.070
     25,000      1.46        25,000      1.46  
0.106
     545,050      2.58        545,050      2.58  
0.856
     2,218,795      3.57        2,218,795      3.57  
2.768
     1,426,495      4.25        1,426,495      4.25  
3.102
     1,445,855      4.73        1,445,855      4.73  
3.560
     1,629,030      5.21        1,629,030      5.21  
5.234
     203,765      6.01        203,765      6.01  
5.650
     2,334,810      6.40        2,125,470      6.39  
5.846
     1,802,595      7.59        1,164,672      7.57  
6.006
     5,907,345      8.52        2,283,987      8.50  
6.190
     7,845,702      9.4        2,545,133      9.26  
  
 
 
       
 
 
    
     25,620,937         15,849,747   
  
 
 
       
 
 
    
 
Schedule of share based payment award stock options valuation assumptions
The fair value of the employee stock options granted during the nine months ended October 31, 2021 and 2020 was estimated using the following assumptions:
 
    
Nine Months Ended October 31,
    
2021
  
2020
Weighted-average expected term (years)
  
2.62 - 7.32
  
5.08 - 6.65
Expected volatility
  
42.45% - 48.39%
  
42.45% - 44.28%
Risk-free interest rate
  
0.37% - 1.23%
  
0.31% - 0.46%
Dividend yield
   0.00%    0.00%
The fair value of shares vested during the year ended January 31, 2021 was $10.2 million. The fair value of the employee stock options granted during the years ended January 31, 2021 and 2020 was estimated using the following assumptions:
 
    
Year Ended January 31,
 
    
2021
   
2020
 
Weighted-average expected term (years)
    
5.02 - 6.76
     
5.08 - 6.83
 
Expected volatility
    
42.45% - 44.71
   
38.13% - 39.85
Risk-free interest rate
    
0.31% - 0.52
   
1.67% - 2.54
Dividend yield
     —         —    
Share based payment arrangement expensed and capitalized amount
Stock-based compensation expense related to options granted to employees and nonemployees was recognized as follows:
 
    
Nine Months Ended October 31,
 
(in thousands)   
        2021        
    
        2020        
 
Cost of revenue
   $ 688    $ 585
Research and development
     4,582      2,898
Sales and marketing
     1,959      1,193
General and administrative
     5,904      6,805
  
 
 
    
 
 
 
Total expense
   $ 13,133    $ 11,481
Capitalized
internal-use
software development costs
     (514      (392
  
 
 
    
 
 
 
Total stock-based compensation expense
   $ 12,619    $ 11,089
  
 
 
    
 
 
 
Stock-based compensation expense related to options granted to employees and nonemployees was recognized as follows:
 
    
Year Ended
January 31,
 
(in thousands)
  
2021
    
2020
 
Cost of revenue
   $ 843    $ 788
Research and development
     4,109      2,754
Sales and marketing
     1,687      1,234
General and administrative
     7,899      1,252
  
 
 
    
 
 
 
Total expense
     14,538      6,028
Capitalized internal-use software development costs
     (526      (957
  
 
 
    
 
 
 
Total stock-based compensation expense
   $ 14,012    $ 5,071
  
 
 
    
 
 
 
Share based payment arrangement restricted stock unit activity
A summary of RSU activity under the Plan is as follows:
 
    
Number of
RSUs
    
Weighted
Average
Grant Date
Fair Value
 
Balances at January 31, 2021
     1,085,610    $ 6.09
Granted
     2,531,752   
Forfeited
     (132,359    $ 7.30
  
 
 
    
Balances at October 31, 2021
     3,485,003    $ 11.99
  
 
 
    
 
A summary of RSU activity under the Plan is as follows:
 
    
Number of

RSUs
    
Weighted

Average

Grant Date

Fair Value
 
Balances at February 1, 2019
     803,430    $ 5.985
Vested
     —          —    
Granted
     587,500      6.109
Forfeited
     (450,000      6.041
  
 
 
    
Balances at January 31, 2020
     940,930    $ 6.036
Vested
     —          —    
Granted
     200,000      6.470
Forfeited
     (55,320      5.984
  
 
 
    
Balances at January 31, 2021
     1,085,610    $ 6.091